Related Experiment Video
Updated: Aug 27, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Implementation of melanoma guidelines in the multidisciplinary setting: A qualitative analysis
Nicole M Mott1, Zoey N Duncan2, Cecilia M Pesavento3
1University of Michigan Medical School, Ann Arbor, MI, USA; University of Michigan, Center for Healthcare Outcomes and Policy, Ann Arbor, MI, USA; University of Colorado Anschutz Medical Campus, Department of Surgery, Aurora, CO, USA.
Melanoma treatment varies, with differing views on completion lymph node dissection and adjuvant therapy. Improving multidisciplinary care requires consensus on data interpretation and surveillance roles for better patient outcomes.
Area of Science:
- Oncology
- Dermatology
- Surgical Oncology
Background:
- Variation exists in the use of completion lymph node dissection (CLND) and adjuvant systemic therapy (AT) for sentinel lymph node-positive melanoma.
- Multidisciplinary treatment approaches are crucial but present challenges in melanoma care.
Purpose of the Study:
- To explore how clinicians consider multidisciplinary treatment options for melanoma.
- To identify challenges and opportunities in current melanoma care practices.
Main Methods:
- Semi-structured interviews were conducted with 26 surgical oncologists, medical oncologists, and otolaryngologists.
- Thematic analysis was used to analyze interview data on melanoma treatment decision-making.
Main Results:
- Participants emphasized the importance of multidisciplinary care, facilitated by shared clinic time.
- Divergent perspectives on CLND and AT were revealed, alongside challenges in patient surveillance and role delineation.
- Concerns were raised regarding nodal ultrasound fidelity and a "surveillance burden" on patients.
Conclusions:
- Opportunities exist to enhance multidisciplinary melanoma care.
- Broader consensus is needed on translating emerging data into patient care and clarifying surveillance roles.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

